loadpatents
name:-0.044059038162231
name:-0.066001176834106
name:-0.0017240047454834
SCHINDLER; Marcus Patent Filings

SCHINDLER; Marcus

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHINDLER; Marcus.The latest application filed is for "method for the additive manufacturing of at least one component of defined component properties".

Company Profile
2.17.35
  • SCHINDLER; Marcus - Schwabisch Hall DE
  • Schindler; Marcus - Hovas SE
  • Schindler; Marcus - Biberach DE
  • Schindler; Marcus - Nuneham Courtenay N/A GB
  • SCHINDLER; Marcus - Sutton Courtenay GB
  • Schindler; Marcus - Oxford GB
  • SCHINDLER; Marcus - Oxfordshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For The Additive Manufacturing Of At Least One Component Of Defined Component Properties
App 20220244703 - SCHINDLER; Marcus
2022-08-04
Use Of Flibanserin In The Treatment Of Obesity
App 20210069185 - Ceci; Angelo ;   et al.
2021-03-11
Use of Flibanserin in the treatment of obesity
Grant 10,874,668 - Ceci , et al. December 29, 2
2020-12-29
Use Of Flibanserin In The Treatment Of Obesity
App 20190282566 - Ceci; Angelo ;   et al.
2019-09-19
Use of flibanserin in the treatment of obesity
Grant 10,335,407 - Ceci , et al.
2019-07-02
Use of Flibanserin in the Treatment of Obesity
App 20180015084 - Ceci; Angelo ;   et al.
2018-01-18
Use of flibanserin in the treatment of obesity
Grant 9,730,927 - Ceci , et al. August 15, 2
2017-08-15
6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
Grant 9,346,816 - Mueller , et al. May 24, 2
2016-05-24
Use of Flibanserin in the Treatment of Obesity
App 20160136161 - Ceci; Angelo ;   et al.
2016-05-19
Use of Flibanserin in the Treatment of Obesity
App 20150072994 - Ceci; Angelo ;   et al.
2015-03-12
Use of flibanserin in the treatment of obesity
Grant 8,785,458 - Ceci , et al. July 22, 2
2014-07-22
6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
App 20140066428 - MUELLER; Stephan-Georg ;   et al.
2014-03-06
Use of Flibanserin in the Treatment of Obesity
App 20130079355 - Ceci; Angelo ;   et al.
2013-03-28
Use of flibanserin in the treatment of obesity
Grant 8,227,476 - Ceci , et al. July 24, 2
2012-07-24
6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
App 20120165304 - Mueller; Stephan-Georg ;   et al.
2012-06-28
New Pyridone Derivates With Mch Antagonistic Activity And Medicaments Comprising These Compounds
App 20120010185 - STENKAMP; Dirk ;   et al.
2012-01-12
Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds
Grant 8,067,590 - Stenkamp , et al. November 29, 2
2011-11-29
Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds
App 20100197908 - Lehmann-Lintz; Thorsten ;   et al.
2010-08-05
CGRP Antagonists
App 20100152171 - RUDOLF; Klaus ;   et al.
2010-06-17
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
App 20100113411 - RUDOLF; Klaus ;   et al.
2010-05-06
CGRP antagonists
Grant 7,700,589 - Rudolf , et al. April 20, 2
2010-04-20
.beta.-ketoamide compounds with MCH antagonistic activity
Grant 7,605,176 - Roth , et al. October 20, 2
2009-10-20
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
Grant 7,595,312 - Rudolf , et al. September 29, 2
2009-09-29
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
Grant 7,592,358 - Stenkamp , et al. September 22, 2
2009-09-22
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
Grant 7,592,373 - Lehmann-Lintz , et al. September 22, 2
2009-09-22
Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
Grant 7,538,115 - Hurnaus , et al. May 26, 2
2009-05-26
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
Grant 7,524,862 - Stenkamp , et al. April 28, 2
2009-04-28
New Pyridone Derivates With Mch Antagonistic Activity And Medicaments Comprising These Compounds
App 20080255083 - Stenkamp; Dirk ;   et al.
2008-10-16
Use of Flibanserin in the Treatment of Obesity
App 20080242678 - Ceci; Angelo ;   et al.
2008-10-02
CGRP Antagonists
App 20070244099 - RUDOLF; Klaus ;   et al.
2007-10-18
Compounds and compositions for treating obesity
App 20070185128 - Conde-Frieboes; Kilian Waldemar ;   et al.
2007-08-09
New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds
App 20070111981 - Roth; Gerald Juergen ;   et al.
2007-05-17
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
App 20060079504 - Rudolf; Klaus ;   et al.
2006-04-13
Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
Grant 7,026,312 - Hurnaus , et al. April 11, 2
2006-04-11
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
App 20050267120 - Stenkamp, Dirk ;   et al.
2005-12-01
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
App 20050267115 - Stenkamp, Dirk ;   et al.
2005-12-01
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
App 20050267093 - Lehmann-Lintz, Thorsten ;   et al.
2005-12-01
Beta-ketoamide compounds with MCH antagonistic activity
App 20050245500 - Roth, Gerald Juergen ;   et al.
2005-11-03
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
App 20050245529 - Stenkamp, Dirk ;   et al.
2005-11-03
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
App 20050239826 - Stenkamp, Dirk ;   et al.
2005-10-27
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
App 20050234101 - Stenkamp, Dirk ;   et al.
2005-10-20
Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
App 20050215546 - Hurnaus, Rudolf ;   et al.
2005-09-29
Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof
App 20040192729 - Rudolf, Klaus ;   et al.
2004-09-30
CGRP antagonists
App 20040132716 - Rudolf, Klaus ;   et al.
2004-07-08
Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
App 20030236282 - Hurnaus, Rudolf ;   et al.
2003-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed